2L9

BLUEPRINT MEDICINES CORP

Institutional Ownership · Q4 2025

Filing: Q4 2025

BLUEPRINT MEDICINES CORP (2L9) is held by 2 institutional investors with combined holdings of $3M. Major holders include DekaBank Deutsche Girozen, HUNTINGTON NATIONAL BANK.

💰 Dark Pool Activity 👤 Insider Trades

Institutional Holders

Total Value

$2.6M

Ownership %

—

🏦 Top Institutional Holders

DekaBank Deutsche Girozentrale

25.9K shares

$2.6M

HUNTINGTON NATIONAL BANK

1 shares

$129

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.